Acciones RegeneRx Biopharmaceuticals, Inc. Other OTC
Acciones
RGRX
US75886X1081
Farmacéuticos
Ventas 2021 | 76,76 mil 70,72 mil | Ventas 2022 | 76,76 mil 70,72 mil | Capitalización | 19,94 M 18,37 M |
---|---|---|---|---|---|
Resultado Neto 2021 | -1 M -921 mil | Resultado Neto 2022 | -1 M -921 mil | VE / Ventas 2021 | 298 x |
Posición de caja neta 2021 | 66,69 mil 61,44 mil | Deuda neta 2022 | 1,16 M 1,06 M | VE / Ventas 2022 | 275 x |
P/E ratio 2021 |
-13,9
x | P/E ratio 2022 |
-11,5
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 55,86 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 86 | 13/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Founder | 86 | 13/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 01/01/02 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-3,08 % | 89,49 mil M | |
+2,50 % | 40,67 mil M | |
-12,01 % | 33,15 mil M | |
+62,74 % | 26,45 mil M | |
-19,79 % | 14,69 mil M | |
-8,58 % | 12,89 mil M | |
-12,34 % | 11,54 mil M | |
-43,92 % | 11,34 mil M | |
+4,27 % | 8841,47 M |